在初级ER阳性和HER2阴性乳腺癌中同源的重组缺陷
Helen R Davies1, Daniella Black1, Anders Kvist2
1Department of Genomic Medicine, School of Clinical Medicine & Early Cancer Institute, University of Cambridge, Cambridge, UK.
Communications medicine
|February 16, 2026
概括
同源复合缺陷 (HRD) 在雌激素受体阳性,HER2阴性乳腺癌 (ERpHER2n BC) 中比在三阴性乳腺癌中少见. 人力资源发展状况可能会影响治疗决策,特别是在化疗使用方面.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 同源复合缺陷 (HRD) 是三阴性乳腺癌 (TNBC) 的可向异常.
- 在雌激素受体阳性,HER2阴性乳腺癌 (ERpHER2n BC) 中,HRD的患病率和临床意义仍然基本未知.
研究的目的:
- 调查HRD在ERpHER2nBC中的流行率,遗传基础和临床影响.
- 将ERpHER2n BC中的HRD特征与TNBC中的特征进行比较.
主要方法:
- 从人口代表性的瑞典SCAN-B研究中分析了502个ERpHER2n瘤.
- 全基因组测序 (WGS) 以定义基于突变特征的HRD.
- 整合匹配的转录,DNA甲基化,临床病理学,治疗和结果数据.
主要成果:
- 在8.4%的ERpHER2nBC病例中发现了HRD,明显低于TNBC.
- HRD机制涉及BRCA1/BRCA2/RAD51C/PALB2无活化,占HRD瘤的71.4%.
- HRD瘤在大多数PAM50亚型中存在,除了Luminal A,并且缺乏明显的转录或DNA甲基化概况.
- 没有HRD和患者结局与结合化疗和内分泌治疗之间的显著关联.
- 对于仅用内分泌疗法治疗的HRD瘤,观察到较差结果的趋势.
结论:
- ERpHER2nHRD瘤表现出侵略性特征,但与HR熟练瘤相比,缺乏明显的分子配置.
- 基于全基因组测序 (WGS) 的HRD分层可能会为治疗策略提供信息.
- 早期证据表明,HRDBC可能从化疗中受益,而没有化疗,结果会更差.
相关概念视频
Homologous Recombination
63.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
63.8K
Homologous Recombination
6.9K
6.9K
Conservative Site-specific Recombination and Phase Variation
6.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.9K
Mismatch Repair
6.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.7K
Long-patch Base Excision Repair
8.1K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
8.1K
Crossing Over
6.7K
Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I,...
6.7K


